Menlo Park, CA, United States of America

Alexander L Huang

This inventor holds 47 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Gastrointestinal Treatments. Top assignees: Liveleaf, Inc., Percutaneous Systems, Inc., Boston Scientific Scimed, Inc.. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander L Huang. Retrieved from https://idiyas.com/inventor/alexander-l-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 

% Patents Active = 70.2


 

Average Co-Inventor Count = 2.2

ph-index = 14

Forward Citations = 1,170(Granted Patents)


Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gastrointestinal Spasms
Tannin Formulation
Hydrogen Peroxide
Bacterial Inhibition
Malnutrition
Ureteral Stents
Pomegranate Extract
Biocidal Solution
Chemotherapy
Diverticulitis
Crohn's Disease
Ulcerative Colitis
47 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Alexander L. Huang

Introduction

Alexander L. Huang, based in Menlo Park, California, is a prolific inventor with an impressive portfolio of 47 patents. His work primarily focuses on biocidal solutions derived from plant-based materials, which demonstrate innovative methodologies to enhance the efficacy of hydrogen peroxide.

Latest Patents

Among his latest patents, Huang has developed methods for increasing the half-life of hydrogen peroxide through the use of polyphenols. The primary invention centers around a method and composition aimed at generating a plant-based biocidal solution. This solution comprises a bioactive material and a plant-derived substance, capable of binding to the bioactive material, specifically hydrogen peroxide. The invention showcases modes of application where the biocidal solution can be utilized against pathogens. Furthermore, it emphasizes the potential of the plant-based substance to form microscopic clusters or aggregates, which could enhance the bioactive material's effectiveness in overcoming the defensive mechanisms of targeted pathogens.

Career Highlights

Huang's career includes significant stints at Liveleaf, Inc. and Percutaneous Systems, Inc., where he contributed to research and development efforts in biocidal and health-related applications. His innovative approaches have positioned him as a thought leader in plant-based solutions and biocidal technologies.

Collaborations

Throughout his career, Huang has collaborated with notable professionals such as Gin Wu and Robert S. Behl. These collaborations have likely enriched his research endeavors, fostering an environment where innovative ideas can flourish and lead to practical applications.

Conclusion

Alexander L. Huang's contributions to the fields of innovation and biocidal solutions are significant, as evidenced by his extensive patent portfolio. His work not only showcases the potential of plant-based materials in modern applications but also highlights a commitment to advancing health and safety solutions. As he continues to innovate, the impact of his inventions will likely resonate across various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…